Guggenheim’s 3rd Annual Neuro/Immunology Conference

Faits marquants

Naimish Patel, Therapeutic Area Head, Immunology & Inflammation Development et Erik Wallstroem, Therapeutic Area Head of Multiple Sclerosis, Neurology and Gene Therapy présentent à la Guggenheim’s 3rd Annual Neuro/Immunology Conference